Bullfrog AI Holdings, Inc. is projected to rise to $0.593 by 2027, a +1% move from its current price of $0.586. BFRG is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/25/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 26 | $0.564 | $0.5859 | $0.6086 | -0.02% |
| Jul 27 | $0.5551 | $0.5858 | $0.6182 | -0.03% |
| Jul 28 | $0.5484 | $0.5857 | $0.6256 | -0.05% |
| Jul 29 | $0.5427 | $0.5856 | $0.6319 | -0.06% |
| Jul 30 | $0.5378 | $0.5855 | $0.6375 | -0.08% |
| Jul 31 | $0.5334 | $0.5855 | $0.6426 | -0.09% |
| Aug 1 | $0.5293 | $0.5854 | $0.6474 | -0.11% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.5293 | $0.5854 | $0.6474 | -0.11% |
| Week 2 | $0.5072 | $0.5847 | $0.6742 | -0.22% |
| Week 3 | $0.4907 | $0.5841 | $0.6953 | -0.32% |
| Week 4 | $0.4771 | $0.5835 | $0.7136 | -0.43% |
| Week 5 | $0.4654 | $0.5828 | $0.7299 | -0.54% |
| Week 6 | $0.455 | $0.5822 | $0.745 | -0.65% |
| Week 7 | $0.4456 | $0.5816 | $0.759 | -0.76% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and BF-222, a novel formulation of mebendazole, which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; and BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases.
The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. It has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.
Bullfrog AI Holdings, Inc. (BFRG) is a healthcare company with a current price of $0.632 per share. Its market cap is $11.72M and it is ranked 4970 by market capitalization. The year-by-year forecast shows averages drifting higher over time, with later years delivering larger prices and notable upside.
In particular, the 2050 average is $2.15, with a maximum forecast of $4.79, suggesting a potential long-horizon upside despite near-term volatility. The forecast also shows varying returns by year, including a 239.6% ROI in 2050, underscoring a high-end upside scenario.
A major floor 13.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.7% away) — a key level to hold.
The nearest ceiling, 25.8% above — a clean break opens room to run.
A major ceiling 186.7% above — clearing it would confirm fresh momentum.
Key BFRG support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BFRG market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6332 | Sell | $0.6313 | Sell |
| MA 10 | $0.6552 | Sell | $0.6481 | Sell |
| MA 20 | $0.6713 | Sell | $0.6626 | Sell |
| MA 50 | $0.6711 | Sell | $0.6866 | Sell |
| MA 100 | $0.7331 | Sell | $0.7332 | Sell |
| MA 200 | $0.8446 | Sell | $0.8969 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.40 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -150.78 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -13.01 | Sell |
| Bollinger %B (20,2) | 0.01 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.13 | Sell |
| Awesome (5,34) | -0.04 | Sell |
| Ultimate (7,14,28) | 22.94 | Buy |
| Momentum (10) | -0.13 | Sell |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 0.62 | Sell |
| ADX (14) | 9.17 | Neutral |
| ATR (14) | 0.02 | Info |
Near-term technical picture remains cautious. The 14-day RSI is 40, indicating bearish momentum in the short run. The stock price is evaluated against the moving averages, with the SMA50 at $0.6756 and the SMA200 at $0.8645.
Traders may watch for a shift in momentum as price action tests key levels. Immediate support is at $0.611 and resistance at $0.77, while the 30-day range spans from $0.4776 to $0.8362.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.457 | $0.586 | $0.7459 | 0% | Neutral | |
| $0.4556 | $0.593 | $0.8257 | +1% | Neutral | |
| $0.4975 | $0.6745 | $0.9866 | +15% | Neutral | |
| $0.5365 | $0.7527 | $1.14 | +28% | Bullish | |
| $0.5173 | $0.7483 | $1.17 | +28% | Bullish | |
| $0.5041 | $0.7498 | $1.21 | +28% | Bullish | |
| $0.4454 | $0.6802 | $1.12 | +16% | Neutral | |
| $0.4232 | $0.6627 | $1.12 | +13% | Neutral | |
| $0.495 | $0.7937 | $1.37 | +35% | Bullish | |
| $0.5601 | $0.9191 | $1.61 | +57% | Bullish | |
| $0.5143 | $0.9391 | $1.78 | +60% | Bullish | |
| $0.869 | $1.93 | $4.08 | +229% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.457 | $0.586 | $0.6862 | +0.00% |
| August 2026 | $0.4696 | $0.5572 | $0.6811 | -4.91% |
| September 2026 | $0.4816 | $0.5778 | $0.7185 | +3.69% |
| October 2026 | $0.4853 | $0.5876 | $0.7408 | +1.69% |
| November 2026 | $0.4659 | $0.5684 | $0.7248 | -3.25% |
| December 2026 | $0.4713 | $0.579 | $0.7459 | +1.86% |
Click any year to see its month-by-month BFRG forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, BFRG is projected to trade between $0.457 and $0.7459, averaging $0.586 — a potential gain of 0% from today's $0.586. Price action looks broadly range-bound.
Bullfrog AI Holdings, Inc.'s 2027 outlook centres on $0.593, within a $0.4556 to $0.8257 range. That is up +1% on the projected 2026 average. That marks a +1% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, BFRG could reach as high as $0.9866, with a base case around $0.6745 and support toward $0.4975 — roughly +15% from $0.586. Price action looks broadly range-bound.
Expect BFRG to range from $0.5365 to $1.14 through 2029. The $0.7527 average target implies a +28% move from current prices. That is up +12% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The BFRG price prediction for 2030 points to an average of $0.7483 (low $0.5173, high $1.17) — a potential gain of +28% on today's $0.586. Momentum favours further upside here.
In 2031, BFRG is projected to trade between $0.5041 and $1.21, averaging $0.7498 — a potential gain of +28% from today's $0.586. That is up 0% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Bullfrog AI Holdings, Inc.'s 2032 outlook centres on $0.6802, within a $0.4454 to $1.12 range. That is -9% versus the projected 2031 average. That marks a +16% change versus current levels. Price action looks broadly range-bound.
By 2033, BFRG could reach as high as $1.12, with a base case around $0.6627 and support toward $0.4232 — roughly +13% from $0.586. A consolidation phase looks the most probable path here.
Expect BFRG to range from $0.495 to $1.37 through 2034. The $0.7937 average target implies a +35% move from current prices. That is up +20% on the projected 2033 average. Momentum favours further upside here.
The BFRG price prediction for 2035 points to an average of $0.9191 (low $0.5601, high $1.61) — a potential gain of +57% on today's $0.586. Buyers look set to stay in control over this stretch.
In 2040, BFRG is projected to trade between $0.5143 and $1.78, averaging $0.9391 — a potential gain of +60% from today's $0.586. That is up +2% on the projected 2035 average. Momentum favours further upside here.
Bullfrog AI Holdings, Inc.'s 2050 outlook centres on $1.93, within a $0.869 to $4.08 range. That is up +105% on the projected 2040 average. That marks a +229% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in BFRG today (≈ 1,706.484642 BFRG) could be worth
$3,290.56
+$2,290.56 (+229%) by 2050 · US Dollar
Based on the average projected BFRG price of $1.93 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BFRGwould be worth at today's price.
$1,000 invested in BFRG on Jul 23, 2025 (≈ 645.16131 BFRG) would be worth
$378.06
-$621.94 (-62.2%) today · 0.38× · US Dollar
Based on a BFRG entry price of $1.55 vs. today's $0.586.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.632 | $927.22 | -7.3% |
| 1 month ago | $0.662 | $885.2 | -11.5% |
| 3 months ago | $0.81 | $723.46 | -27.7% |
| 6 months ago | $0.722 | $811.63 | -18.8% |
| 1 year ago | $1.55 | $378.06 | -62.2% |
| All time (3.4y) ago | $6.5 | $90.15 | -91.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BFRG forecast.
Our base-case forecast reaches $1.20 around 2050.
Implied market cap at $1.20: $22.25M
The multi-year forecast outlines a path toward higher averages and meaningful upside in the outer years. The 2030 average is $0.8214 with a 30% ROI, the 2040 average is $1.01 with a 59% ROI, and the 2050 average is $2.15 with a 239.6% ROI. Earlier years show more modest gains, such as 2029 average $0.8427 with a 33.3% ROI, and 2035 average $1.03 with a 63.2% ROI.
The sequence suggests bullish momentum building from the late 2020s into the 2030s and beyond, but the near term features neutral to bearish sentiment before those gains materialize. The forecast also notes notable upside in the 2034 and 2035 windows, with 2034 average $0.8688 and 2035 average $1.03. An annualized volatility of 80% underscores the elevated risk in the period."
Tap a question to reveal the answer.
2030 avg $0.8214, min $0.5503, max $1.33, ROI 30%.
The forecast shows a bullish path into the late 2020s and 2030s, with 2030 avg $0.8214 (ROI 30%), 2040 avg $1.01 (ROI 59%), and 2050 avg $2.15 (ROI 239.6%). Near term is neutral to bearish, with diverse year-to-year returns (e.g., 2026 ROI 0%, 2029 ROI 33.3%). These are estimates, not guarantees.
Yes. The forecast includes multiple years with max prices above $1, including 2030 max $1.33, 2034 max $1.55, 2035 max $1.88, 2040 max $1.99, and 2050 max $4.79.
The 30-day range is $0.4776 to $0.8362, with the current price at $0.632 and near-term support at $0.611 and resistance at $0.77.
Market cap is $11.72M and the rank is 4970.
Bullfrog AI Holdings, Inc. Community Discussion
0Share your Bullfrog AI Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.